▶ 調査レポート

世界の放射線量管理市場

• 英文タイトル:Radiation Dose Management Market - Growth, Trends, and Forecast (2019 - 2024)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の放射線量管理市場 / Radiation Dose Management Market - Growth, Trends, and Forecast (2019 - 2024) / C-MOR-100213資料のイメージです。• レポートコード:C-MOR-100213
• 出版社/出版日:Mordor Intelligence / 2019年9月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Multi User¥703,000 (USD4,750)▷ お問い合わせ
  Site License¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、放射線量管理の世界市場について調査・分析し、放射線量管理の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。

Market Overview
Radiation overexposure may cause long-term health consequences. In the study carried out by National Institute of Health, to understand the impact of high dose radiation, it is observed that in the United States, patients are exposed to excess radiation brain scans, and the amount of dose received is eight times higher than the normal level. Due to increasing concerns, FDA urged imaging centers and manufacturers to comply with protocols specific to each scanning procedures. The FDA also recommends hospitals to implement dosing protocols for dose adjustment for improving patient safety during CT scans which are usually followed by all the major countries across the globe.

Most hospitals and imaging centers are increasingly adopting new dose reduction technology systems with high-end CT systems. The dose tracking software reduces the burden of manual collection of doses for CT performed in a center. This is also beneficial in the early detection of wrong dose selection. Therefore, the growth of the radiation dose management market is expected in the coming future.

Scope of the Report

Radiation dose management is used in hospitals, imaging centers, and research institutes for estimating a dose required for a procedure (eg: CT scan), to prevent high radiation dose exposure to patients.

Key Market Trends

Computed Tomography is Expected to Register Highest CAGR in the Modality Segment

There has been an increase in radiation exposure in patients who underwent computed tomography (CT), causing burns and radiation poisoning. Due to high dose exposures, while undergoing CT scans, manufacturers are including technology for correct dose estimation for a CT procedure.

New CT equipment with dose reduction hardware and software-embedded technology reduces the risk of radiation exposure to patients. For instance, Bayer’s Radimetric Enterprise Platform automates the dose documentation with the use of Medrad Stellant CT injection system, with Certegra.

The Canon Medical Systems Aquilion One/Genesis Edition CT is able to reduce the need for multimodality exams, as it captures the image of the entire brain with a single 640-slice rotation. It also reduces the noise during the procedure, and the radiation dose is lowered by up to 82.4%. The Aquilion Precision System is the first FDA-approved ultra-high-resolution computed tomography.

With the availability of such advanced products and the awareness about radiation dose management, the market is believed to grow over the forecast period.

The United States Holds the Largest Share in the North America Region

As per the report published by Harvard Medical School, it is estimated that in the United States, more than 80 million CT scans are performed, annually. The scanning procedures revolutionized the diagnosis and treatment, such as CT angiography, colonography, and dual-energy and perfusion CT.

However, there is an increasing concern on the exposure to high doses of radiation, due to risks associated with ionizing radiation. Thus, radiology departments are using low doses for CT scans.

Many research centers and hospitals are using advanced state-of-art CT machines that are integrated with software and ERP’s for accurate estimation of radiation doses that can be compared with reference standards. The dose tracking software calculates the average dose based on the previous CT examination doses. Owing to the aforementioned factors, the US radiation dose management market is expected to grow at a healthy rate over the forecast period.

Competitive Landscape

The market for radiation dose management is moderately competitive and global players are dominating the market. With the rising technological advancements, few new entrants are focusing on product innovation and are penetrating the market. It is believed that these companies will hold a substantial share in the coming future.

Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Stringent Government Regulations About the Radiation Dose
4.2.2 Awareness and Industry Initiatives for Radiation Dose Management
4.2.3 Increasing Concerns over Radiation Overexposure
4.3 Market Restraints
4.3.1 Low Adoption of radiation Dose Management Solutions in Emerging Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Products & Services
5.1.1 Standalone Solutions
5.1.2 Integrated Solutions
5.1.3 Implementation and Integration Services
5.1.4 Support and Maintenance Services
5.1.5 Education and Training Services
5.2 By Modality
5.2.1 Computed Tomography
5.2.2 Fluoroscopy and Interventional Imaging
5.2.3 Nuclear Medicine
5.2.4 Radiography and Mammography
5.3 By End User
5.3.1 Ambulatory Care Settings
5.3.2 Hospital
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Bracco Imaging SpA
6.1.3 Fujifilm Holdings Corporation
6.1.4 GE Healthcare
6.1.5 Medsquare
6.1.6 Novarad Corporation
6.1.7 PACShealth LLC
6.1.8 Koninklijke Philips N.V.
6.1.9 Qaelum NV
6.1.10 Sectra AB
7 MARKET OPPORTUNITIES AND FUTURE TRENDS